SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689375-22-000045
Filing Date
2022-11-07
Accepted
2022-11-07 07:39:56
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q trda-20220930.htm   iXBRL 10-Q 1714391
2 EX-31.1 trda-20220930x10qex311.htm EX-31.1 10362
3 EX-31.2 trda-20220930x10qex312.htm EX-31.2 10371
4 EX-32.1 trda-20220930x10qex321.htm EX-32.1 7342
  Complete submission text file 0001689375-22-000045.txt   5834202

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20220930.xsd EX-101.SCH 35527
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trda-20220930_cal.xml EX-101.CAL 61263
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trda-20220930_def.xml EX-101.DEF 138294
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20220930_lab.xml EX-101.LAB 447801
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20220930_pre.xml EX-101.PRE 292861
60 EXTRACTED XBRL INSTANCE DOCUMENT trda-20220930_htm.xml XML 783733
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40969 | Film No.: 221363757
SIC: 2834 Pharmaceutical Preparations